“The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients With Type 2 Diabetes Mellitus”. 2022. Actual Problems of Medicine and Pharmacy 3 (1): 1-10. https://doi.org/10.52914/apmp.v3i1.42.